Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.
Market Analysis and Insights: Global Hospital Acquired Infections Control Market
The global Hospital Acquired Infections Control market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hospital Acquired Infections Control Scope and Market Size
Hospital Acquired Infections Control market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Advanced Sterilization Products
Becton Dickinson
Belimed AG
bioMerieux
Cantel
Cepheid
Getinge
Merck & Co.
Nordion
Pfizer
Roche
Sakura Seiki
Steris
TSO3
Hospital Acquired Infections Control Breakdown Data by Type
Diagnostic techniques
Dleaning and sterilization
Treatment
Hospital Acquired Infections Control Breakdown Data by Application
General Hospital
Infectious Disease Hospital
Market Analysis and Insights: Global Hospital Acquired Infections Control Market
The global Hospital Acquired Infections Control market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hospital Acquired Infections Control Scope and Market Size
Hospital Acquired Infections Control market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections Control market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Advanced Sterilization Products
Becton Dickinson
Belimed AG
bioMerieux
Cantel
Cepheid
Getinge
Merck & Co.
Nordion
Pfizer
Roche
Sakura Seiki
Steris
TSO3
Hospital Acquired Infections Control Breakdown Data by Type
Diagnostic techniques
Dleaning and sterilization
Treatment
Hospital Acquired Infections Control Breakdown Data by Application
General Hospital
Infectious Disease Hospital
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Infections Control Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Infections Control Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostic techniques
1.4.3 Dleaning and sterilization
1.4.4 Treatment
1.5 Market by Application
1.5.1 Global Hospital Acquired Infections Control Market Share by Application: 2020 VS 2026
1.5.2 General Hospital
1.5.3 Infectious Disease Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections Control Market Perspective (2015-2026)
2.2 Global Hospital Acquired Infections Control Growth Trends by Regions
2.2.1 Hospital Acquired Infections Control Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Infections Control Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Infections Control Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Infections Control Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Infections Control Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections Control Players by Market Size
3.1.1 Global Top Hospital Acquired Infections Control Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Infections Control Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Infections Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Infections Control Market Concentration Ratio
3.2.1 Global Hospital Acquired Infections Control Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Control Revenue in 2019
3.3 Hospital Acquired Infections Control Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Infections Control Product Solution and Service
3.5 Date of Enter into Hospital Acquired Infections Control Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Infections Control Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Infections Control Market Size (2015-2020)
6.2 Hospital Acquired Infections Control Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Infections Control Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Infections Control Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Infections Control Market Size (2015-2020)
7.2 Hospital Acquired Infections Control Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Infections Control Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Infections Control Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Infections Control Market Size (2015-2020)
8.2 Hospital Acquired Infections Control Key Players in China (2019-2020)
8.3 China Hospital Acquired Infections Control Market Size by Type (2015-2020)
8.4 China Hospital Acquired Infections Control Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Infections Control Market Size (2015-2020)
9.2 Hospital Acquired Infections Control Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Infections Control Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Infections Control Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Infections Control Market Size (2015-2020)
10.2 Hospital Acquired Infections Control Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Infections Control Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Infections Control Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Infections Control Market Size (2015-2020)
11.2 Hospital Acquired Infections Control Key Players in India (2019-2020)
11.3 India Hospital Acquired Infections Control Market Size by Type (2015-2020)
11.4 India Hospital Acquired Infections Control Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Infections Control Market Size (2015-2020)
12.2 Hospital Acquired Infections Control Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Infections Control Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Infections Control Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Advanced Sterilization Products
13.1.1 Advanced Sterilization Products Company Details
13.1.2 Advanced Sterilization Products Business Overview
13.1.3 Advanced Sterilization Products Hospital Acquired Infections Control Introduction
13.1.4 Advanced Sterilization Products Revenue in Hospital Acquired Infections Control Business (2015-2020))
13.1.5 Advanced Sterilization Products Recent Development
13.2 Becton Dickinson
13.2.1 Becton Dickinson Company Details
13.2.2 Becton Dickinson Business Overview
13.2.3 Becton Dickinson Hospital Acquired Infections Control Introduction
13.2.4 Becton Dickinson Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.2.5 Becton Dickinson Recent Development
13.3 Belimed AG
13.3.1 Belimed AG Company Details
13.3.2 Belimed AG Business Overview
13.3.3 Belimed AG Hospital Acquired Infections Control Introduction
13.3.4 Belimed AG Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.3.5 Belimed AG Recent Development
13.4 bioMerieux
13.4.1 bioMerieux Company Details
13.4.2 bioMerieux Business Overview
13.4.3 bioMerieux Hospital Acquired Infections Control Introduction
13.4.4 bioMerieux Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.4.5 bioMerieux Recent Development
13.5 Cantel
13.5.1 Cantel Company Details
13.5.2 Cantel Business Overview
13.5.3 Cantel Hospital Acquired Infections Control Introduction
13.5.4 Cantel Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.5.5 Cantel Recent Development
13.6 Cepheid
13.6.1 Cepheid Company Details
13.6.2 Cepheid Business Overview
13.6.3 Cepheid Hospital Acquired Infections Control Introduction
13.6.4 Cepheid Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.6.5 Cepheid Recent Development
13.7 Getinge
13.7.1 Getinge Company Details
13.7.2 Getinge Business Overview
13.7.3 Getinge Hospital Acquired Infections Control Introduction
13.7.4 Getinge Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.7.5 Getinge Recent Development
13.8 Merck & Co.
13.8.1 Merck & Co. Company Details
13.8.2 Merck & Co. Business Overview
13.8.3 Merck & Co. Hospital Acquired Infections Control Introduction
13.8.4 Merck & Co. Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.8.5 Merck & Co. Recent Development
13.9 Nordion
13.9.1 Nordion Company Details
13.9.2 Nordion Business Overview
13.9.3 Nordion Hospital Acquired Infections Control Introduction
13.9.4 Nordion Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.9.5 Nordion Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Hospital Acquired Infections Control Introduction
13.10.4 Pfizer Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.10.5 Pfizer Recent Development
13.11 Roche
10.11.1 Roche Company Details
10.11.2 Roche Business Overview
10.11.3 Roche Hospital Acquired Infections Control Introduction
10.11.4 Roche Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.11.5 Roche Recent Development
13.12 Sakura Seiki
10.12.1 Sakura Seiki Company Details
10.12.2 Sakura Seiki Business Overview
10.12.3 Sakura Seiki Hospital Acquired Infections Control Introduction
10.12.4 Sakura Seiki Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.12.5 Sakura Seiki Recent Development
13.13 Steris
10.13.1 Steris Company Details
10.13.2 Steris Business Overview
10.13.3 Steris Hospital Acquired Infections Control Introduction
10.13.4 Steris Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.13.5 Steris Recent Development
13.14 TSO3
10.14.1 TSO3 Company Details
10.14.2 TSO3 Business Overview
10.14.3 TSO3 Hospital Acquired Infections Control Introduction
10.14.4 TSO3 Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.14.5 TSO3 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Infections Control Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Infections Control Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostic techniques
1.4.3 Dleaning and sterilization
1.4.4 Treatment
1.5 Market by Application
1.5.1 Global Hospital Acquired Infections Control Market Share by Application: 2020 VS 2026
1.5.2 General Hospital
1.5.3 Infectious Disease Hospital
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections Control Market Perspective (2015-2026)
2.2 Global Hospital Acquired Infections Control Growth Trends by Regions
2.2.1 Hospital Acquired Infections Control Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Infections Control Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Infections Control Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Infections Control Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Infections Control Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections Control Players by Market Size
3.1.1 Global Top Hospital Acquired Infections Control Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Infections Control Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Infections Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Infections Control Market Concentration Ratio
3.2.1 Global Hospital Acquired Infections Control Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections Control Revenue in 2019
3.3 Hospital Acquired Infections Control Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Infections Control Product Solution and Service
3.5 Date of Enter into Hospital Acquired Infections Control Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Infections Control Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Infections Control Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Infections Control Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Infections Control Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Infections Control Market Size (2015-2020)
6.2 Hospital Acquired Infections Control Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Infections Control Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Infections Control Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Infections Control Market Size (2015-2020)
7.2 Hospital Acquired Infections Control Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Infections Control Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Infections Control Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Infections Control Market Size (2015-2020)
8.2 Hospital Acquired Infections Control Key Players in China (2019-2020)
8.3 China Hospital Acquired Infections Control Market Size by Type (2015-2020)
8.4 China Hospital Acquired Infections Control Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Infections Control Market Size (2015-2020)
9.2 Hospital Acquired Infections Control Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Infections Control Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Infections Control Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Infections Control Market Size (2015-2020)
10.2 Hospital Acquired Infections Control Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Infections Control Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Infections Control Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Infections Control Market Size (2015-2020)
11.2 Hospital Acquired Infections Control Key Players in India (2019-2020)
11.3 India Hospital Acquired Infections Control Market Size by Type (2015-2020)
11.4 India Hospital Acquired Infections Control Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Infections Control Market Size (2015-2020)
12.2 Hospital Acquired Infections Control Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Infections Control Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Infections Control Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Advanced Sterilization Products
13.1.1 Advanced Sterilization Products Company Details
13.1.2 Advanced Sterilization Products Business Overview
13.1.3 Advanced Sterilization Products Hospital Acquired Infections Control Introduction
13.1.4 Advanced Sterilization Products Revenue in Hospital Acquired Infections Control Business (2015-2020))
13.1.5 Advanced Sterilization Products Recent Development
13.2 Becton Dickinson
13.2.1 Becton Dickinson Company Details
13.2.2 Becton Dickinson Business Overview
13.2.3 Becton Dickinson Hospital Acquired Infections Control Introduction
13.2.4 Becton Dickinson Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.2.5 Becton Dickinson Recent Development
13.3 Belimed AG
13.3.1 Belimed AG Company Details
13.3.2 Belimed AG Business Overview
13.3.3 Belimed AG Hospital Acquired Infections Control Introduction
13.3.4 Belimed AG Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.3.5 Belimed AG Recent Development
13.4 bioMerieux
13.4.1 bioMerieux Company Details
13.4.2 bioMerieux Business Overview
13.4.3 bioMerieux Hospital Acquired Infections Control Introduction
13.4.4 bioMerieux Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.4.5 bioMerieux Recent Development
13.5 Cantel
13.5.1 Cantel Company Details
13.5.2 Cantel Business Overview
13.5.3 Cantel Hospital Acquired Infections Control Introduction
13.5.4 Cantel Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.5.5 Cantel Recent Development
13.6 Cepheid
13.6.1 Cepheid Company Details
13.6.2 Cepheid Business Overview
13.6.3 Cepheid Hospital Acquired Infections Control Introduction
13.6.4 Cepheid Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.6.5 Cepheid Recent Development
13.7 Getinge
13.7.1 Getinge Company Details
13.7.2 Getinge Business Overview
13.7.3 Getinge Hospital Acquired Infections Control Introduction
13.7.4 Getinge Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.7.5 Getinge Recent Development
13.8 Merck & Co.
13.8.1 Merck & Co. Company Details
13.8.2 Merck & Co. Business Overview
13.8.3 Merck & Co. Hospital Acquired Infections Control Introduction
13.8.4 Merck & Co. Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.8.5 Merck & Co. Recent Development
13.9 Nordion
13.9.1 Nordion Company Details
13.9.2 Nordion Business Overview
13.9.3 Nordion Hospital Acquired Infections Control Introduction
13.9.4 Nordion Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.9.5 Nordion Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Hospital Acquired Infections Control Introduction
13.10.4 Pfizer Revenue in Hospital Acquired Infections Control Business (2015-2020)
13.10.5 Pfizer Recent Development
13.11 Roche
10.11.1 Roche Company Details
10.11.2 Roche Business Overview
10.11.3 Roche Hospital Acquired Infections Control Introduction
10.11.4 Roche Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.11.5 Roche Recent Development
13.12 Sakura Seiki
10.12.1 Sakura Seiki Company Details
10.12.2 Sakura Seiki Business Overview
10.12.3 Sakura Seiki Hospital Acquired Infections Control Introduction
10.12.4 Sakura Seiki Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.12.5 Sakura Seiki Recent Development
13.13 Steris
10.13.1 Steris Company Details
10.13.2 Steris Business Overview
10.13.3 Steris Hospital Acquired Infections Control Introduction
10.13.4 Steris Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.13.5 Steris Recent Development
13.14 TSO3
10.14.1 TSO3 Company Details
10.14.2 TSO3 Business Overview
10.14.3 TSO3 Hospital Acquired Infections Control Introduction
10.14.4 TSO3 Revenue in Hospital Acquired Infections Control Business (2015-2020)
10.14.5 TSO3 Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
